Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 15 2025
0mins
Should l Buy INTC?
Source: Benzinga
Market Fluctuations: U.S. stock futures showed mixed movements following a hot Producer Price Index report, raising concerns about potential interest rate cuts by the Federal Reserve, while major indices like the Dow Jones and S&P 500 experienced slight changes in their values.
Corporate Developments: President Trump called for Intel CEO Lip-Bu Tan's resignation over alleged ties to China, while notable stock movements included UnitedHealth Group soaring after investments from prominent investors, and Deere & Co. shares falling due to lowered income outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INTC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INTC
Wall Street analysts forecast INTC stock price to fall
29 Analyst Rating
5 Buy
19 Hold
5 Sell
Hold
Current: 44.130
Low
20.00
Averages
39.30
High
52.00
Current: 44.130
Low
20.00
Averages
39.30
High
52.00
About INTC
Intel Corporation is a global designer and manufacturer of semiconductor products. The Company operates through three segments: Intel Products, Intel Foundry, and All Other. Its Intel Products segment includes Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX). The CCG is bringing together the operating system, system architecture, hardware, and software application integration to enable PC experiences. DCAI delivers workload-optimized solutions to cloud service providers and enterprises, along with silicon devices for communications service providers, network and edge, and HPC customers. NEX helps networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Intel Foundry segment comprises technology development, manufacturing and foundry services. All Other segments include Altera, Mobileye, Other.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intel to Report Q1 Financial Results on April 23, 2026
- Earnings Report Schedule: Intel has announced that it will release its Q1 financial results on April 23, 2026, after market close, reflecting the company's commitment to transparency and timely information for investors.
- Conference Call Timing: Following the earnings release, Intel will hold a conference call at 2 p.m. PT that day to discuss the results, enhancing investor interaction and potentially boosting market confidence.
- Webcast Availability: Investors can access a live webcast of the earnings conference call on Intel's Investor Relations website, ensuring broad dissemination of information and further enhancing company transparency and investor engagement.
- Company Background: Intel focuses on designing and manufacturing advanced semiconductors that drive modern computing, emphasizing its ongoing efforts in technological innovation and market leadership.
See More
Intel to Repurchase 49% Stake in Ireland Facility for $14.2 Billion
- Share Buyback Agreement: Intel has reached a deal to repurchase Apollo's 49% equity interest in the Fab 34 joint venture for $14.2 billion, which will provide the company with stronger capital support during its manufacturing expansion and is expected to enhance future profitability.
- Funding Strategy: Intel plans to finance the buyback with cash on hand and approximately $6.5 billion in new debt, a strategy that not only optimizes its capital structure but could also strengthen the company's credit rating in 2027 and beyond.
- Technological Production Capacity: The Fab 34 facility produces chips using Intel 4 and Intel 3 process technologies, including processors for AI-enabled systems, indicating the company's ongoing investment and innovation in high-growth sectors.
- Improved Financial Position: CFO David Zinsner noted that the company's balance sheet and business strategy have significantly improved since the original partnership was formed, indicating Intel's gradual recovery of its leadership position in the competitive semiconductor market.
See More
US Stocks Rise on Optimism Over Middle East Conflict Resolution
- Market Rally: The S&P 500 Index rose by 0.97%, the Dow Jones Industrial Average by 0.86%, and the Nasdaq 100 by 1.45%, reflecting growing investor confidence amid optimism that the Middle East conflict may soon conclude, which could stabilize global markets.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, indicating robust economic recovery that may influence Federal Reserve policy decisions.
- Interest Rate Outlook: Despite a mere 1% chance of a 25 basis point rate hike at the upcoming FOMC meeting, hawkish comments from St. Louis Fed President raised concerns about inflation and employment risks, potentially affecting investor sentiment and market dynamics.
- Divergent Stock Performances: Target Hospitality surged by over 37% after securing a multi-year contract worth over $550 million, while Nike fell by more than 13% due to revenue forecasts indicating a decline, highlighting varied market reactions to company-specific news.
See More
Eli Lilly Gains FDA Approval, Shares Rise
- FDA Drug Approval: Eli Lilly's once-daily GLP-1 pill Foundayo received FDA approval, leading to a 4% rise in shares, which will enhance the company's competitive edge in the obesity treatment market and drive future sales growth.
- Cybersecurity Incident Impact: Hasbro's shares fell over 4% due to a cybersecurity incident involving unauthorized network access, with the company investigating the full impact and implementing protective measures, potentially increasing operational costs in the short term.
- Tobacco Product Delay: Philip Morris International's shares dropped more than 5% after the FDA delayed authorization for nicotine pouch sales, which may hinder the company's future market expansion plans, particularly among new user demographics.
- Semiconductor Buyback Plan: Intel announced a $14.2 billion buyback of a 49% stake in its Ireland Fab 34 joint venture, resulting in a 9% increase in shares, with funding sourced from cash on hand and approximately $6.5 billion in new debt, expected to strengthen its position in the global semiconductor market.
See More
US Stocks Rise on Optimism Over Middle East Conflict Resolution
- Market Optimism: The S&P 500 index rose by 0.52%, the Dow Jones Industrial Average by 0.43%, and the Nasdaq 100 by 0.68%, reflecting investor optimism regarding a potential resolution to the Middle East conflict, which has fueled a continuation of Tuesday's strong rally.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, exceeding the anticipated 0.5%, bolstering market confidence in economic recovery and potentially influencing future monetary policy.
- Interest Rate Expectations: Despite hawkish comments from the St. Louis Fed President putting pressure on stocks, the market is still pricing in only a 1% chance of a 25 basis point rate hike at the upcoming FOMC meeting on April 28-29, indicating a cautious optimism regarding economic growth.
- Notable Stock Performances: Target Hospitality's stock surged over 28% after securing a multi-year contract worth over $550 million, while nCino's forecast of $569 million to $573 million in subscription revenue for 2027 exceeded market expectations, highlighting strong demand in the tech and service sectors.
See More
Intel to Repurchase 49% Stake in Ireland Factory for $14.2 Billion
- Share Buyback Plan: Intel announced it will repurchase its 49% stake in the Fab 34 chip facility in Ireland for $14.2 billion, enhancing its control in chip manufacturing and expected to boost its market competitiveness.
- Increased Financial Flexibility: Intel's CFO stated that this buyback is based on the 2024 agreement with Apollo Global Management, and post-repurchase, the company will have a stronger balance sheet and financial discipline, enabling acceleration of critical initiatives.
- Market Demand Recovery: With the resurgence in demand for central processing units (CPUs), Intel's Fab 34 in Ireland will continue to produce PC and server CPUs, despite its technology nodes being less advanced than the 18A nodes in Arizona, it still meets market needs.
- Strategic Transformation Signal: This buyback signifies Intel's regained market confidence after significant investments and strategic adjustments, highlighting the company's emphasis on CPUs in the AI era, which is expected to drive future growth.
See More
Intel to Report Q1 Financial Results on April 23, 2026
- Earnings Report Schedule: Intel has announced that it will release its Q1 financial results on April 23, 2026, after market close, reflecting the company's commitment to transparency and timely information for investors.
- Conference Call Timing: Following the earnings release, Intel will hold a conference call at 2 p.m. PT that day to discuss the results, enhancing investor interaction and potentially boosting market confidence.
- Webcast Availability: Investors can access a live webcast of the earnings conference call on Intel's Investor Relations website, ensuring broad dissemination of information and further enhancing company transparency and investor engagement.
- Company Background: Intel focuses on designing and manufacturing advanced semiconductors that drive modern computing, emphasizing its ongoing efforts in technological innovation and market leadership.
See More
Intel to Repurchase 49% Stake in Ireland Facility for $14.2 Billion
- Share Buyback Agreement: Intel has reached a deal to repurchase Apollo's 49% equity interest in the Fab 34 joint venture for $14.2 billion, which will provide the company with stronger capital support during its manufacturing expansion and is expected to enhance future profitability.
- Funding Strategy: Intel plans to finance the buyback with cash on hand and approximately $6.5 billion in new debt, a strategy that not only optimizes its capital structure but could also strengthen the company's credit rating in 2027 and beyond.
- Technological Production Capacity: The Fab 34 facility produces chips using Intel 4 and Intel 3 process technologies, including processors for AI-enabled systems, indicating the company's ongoing investment and innovation in high-growth sectors.
- Improved Financial Position: CFO David Zinsner noted that the company's balance sheet and business strategy have significantly improved since the original partnership was formed, indicating Intel's gradual recovery of its leadership position in the competitive semiconductor market.
See More
US Stocks Rise on Optimism Over Middle East Conflict Resolution
- Market Rally: The S&P 500 Index rose by 0.97%, the Dow Jones Industrial Average by 0.86%, and the Nasdaq 100 by 1.45%, reflecting growing investor confidence amid optimism that the Middle East conflict may soon conclude, which could stabilize global markets.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, indicating robust economic recovery that may influence Federal Reserve policy decisions.
- Interest Rate Outlook: Despite a mere 1% chance of a 25 basis point rate hike at the upcoming FOMC meeting, hawkish comments from St. Louis Fed President raised concerns about inflation and employment risks, potentially affecting investor sentiment and market dynamics.
- Divergent Stock Performances: Target Hospitality surged by over 37% after securing a multi-year contract worth over $550 million, while Nike fell by more than 13% due to revenue forecasts indicating a decline, highlighting varied market reactions to company-specific news.
See More
Eli Lilly Gains FDA Approval, Shares Rise
- FDA Drug Approval: Eli Lilly's once-daily GLP-1 pill Foundayo received FDA approval, leading to a 4% rise in shares, which will enhance the company's competitive edge in the obesity treatment market and drive future sales growth.
- Cybersecurity Incident Impact: Hasbro's shares fell over 4% due to a cybersecurity incident involving unauthorized network access, with the company investigating the full impact and implementing protective measures, potentially increasing operational costs in the short term.
- Tobacco Product Delay: Philip Morris International's shares dropped more than 5% after the FDA delayed authorization for nicotine pouch sales, which may hinder the company's future market expansion plans, particularly among new user demographics.
- Semiconductor Buyback Plan: Intel announced a $14.2 billion buyback of a 49% stake in its Ireland Fab 34 joint venture, resulting in a 9% increase in shares, with funding sourced from cash on hand and approximately $6.5 billion in new debt, expected to strengthen its position in the global semiconductor market.
See More
US Stocks Rise on Optimism Over Middle East Conflict Resolution
- Market Optimism: The S&P 500 index rose by 0.52%, the Dow Jones Industrial Average by 0.43%, and the Nasdaq 100 by 0.68%, reflecting investor optimism regarding a potential resolution to the Middle East conflict, which has fueled a continuation of Tuesday's strong rally.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, exceeding the anticipated 0.5%, bolstering market confidence in economic recovery and potentially influencing future monetary policy.
- Interest Rate Expectations: Despite hawkish comments from the St. Louis Fed President putting pressure on stocks, the market is still pricing in only a 1% chance of a 25 basis point rate hike at the upcoming FOMC meeting on April 28-29, indicating a cautious optimism regarding economic growth.
- Notable Stock Performances: Target Hospitality's stock surged over 28% after securing a multi-year contract worth over $550 million, while nCino's forecast of $569 million to $573 million in subscription revenue for 2027 exceeded market expectations, highlighting strong demand in the tech and service sectors.
See More
Intel to Repurchase 49% Stake in Ireland Factory for $14.2 Billion
- Share Buyback Plan: Intel announced it will repurchase its 49% stake in the Fab 34 chip facility in Ireland for $14.2 billion, enhancing its control in chip manufacturing and expected to boost its market competitiveness.
- Increased Financial Flexibility: Intel's CFO stated that this buyback is based on the 2024 agreement with Apollo Global Management, and post-repurchase, the company will have a stronger balance sheet and financial discipline, enabling acceleration of critical initiatives.
- Market Demand Recovery: With the resurgence in demand for central processing units (CPUs), Intel's Fab 34 in Ireland will continue to produce PC and server CPUs, despite its technology nodes being less advanced than the 18A nodes in Arizona, it still meets market needs.
- Strategic Transformation Signal: This buyback signifies Intel's regained market confidence after significant investments and strategic adjustments, highlighting the company's emphasis on CPUs in the AI era, which is expected to drive future growth.
See More
